Resources
Effective diagnostics are usually developed over time. MARTI’s IP is founded in research out of the University of Pretoria. Details of relevant peer-reviewed publications are below.
Scientific publications
Schleicher, G.K., Feldman, C., Vermaak, Y., Verschoor, J.A., 2002. Prevalence of anti-mycolic acid antibodies in patients with pulmonary tuberculosis co-infected with HIV. Clinical Chemistry and Laboratory Medicine 40, 882-887.
http://www.ncbi.nlm.nih.gov/pubmed/12435104
Lemmer, Y., Thanyani, S.T., Vrey, P.J., Driver, C.H.S., Venter, L., van Wyngaardt, S., ten Bokum, A.M.C., Ozoemena, K.I., Pilcher, L.A., Fernig, D.G., Stoltz, A.C., Swai, H.S., Verschoor, J.A., Nejat, D., 2009. Chapter 5 Detection of antimycolic acid antibodies by liposomal biosensors, Methods in Enzymology. Academic Press, 79-104.
http://www.sciencedirect.com/science/article/pii/S0076687909640052
Ozoemena, K., Mathebula, N.S., Jeseelan, P., Toschi, G., Verschoor, J.A., 2010. Electron transfer dynamics across self-assembled N-(2-mercaptoethyl)octadecanamide/mycolic acid layers: impedimetric insights into the structural integrity and interaction with anti-mycolic acid antibodies. Physical Chemistry Chemical Physics 12, 345-357.
http://www.ncbi.nlm.nih.gov/pubmed/20023812
WHO publications
Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis. Policy Statement
WHO Global Tuberculosis Report 2015
FIND publications
FIND Strategy for Tuberculosis 2015-2020
